{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:59:15Z","timestamp":1790909955740,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ekir.2024.10.006","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T22:08:32Z","timestamp":1728770912000},"page":"177-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effective Newborn Screening for Type 1 and 3 Primary Hyperoxaluria"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8120-3306","authenticated-orcid":false,"given":"Bernd","family":"Hoppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Martin-Higueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodovica","family":"Borghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Kaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Reusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo B.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Walli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Janzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Hegert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Janzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Hohenfellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2024.10.006_bib1","series-title":"Principles and practice of screening for disease. J R Coll Gen Pract","first-page":"318","volume":"16","author":"Wilson","year":"1968"},{"key":"10.1016\/j.ekir.2024.10.006_bib2","article-title":"Molecular based newborn screening in Germany: follow-up for cystinosis","volume":"21","author":"Hohenfellner","year":"2019","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.ekir.2024.10.006_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41431-019-0476-4","article-title":"High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR","volume":"28","author":"Czibere","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ekir.2024.10.006_bib4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJMra1301564","article-title":"Primary hyperoxaluria","volume":"369","author":"Cochat","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2024.10.006_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrneph.2012.113","article-title":"An update on primary hyperoxaluria","volume":"8","author":"Hoppe","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2024.10.006_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.615183","article-title":"The struggling odyssey of infantile primary hyperoxaluria","volume":"9","author":"Guillaume","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ekir.2024.10.006_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","article-title":"Lumasiran, an RNAi therapeutic for primary hyperoxaluria Type 1","volume":"384","author":"Garrelfs","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2024.10.006_bib8","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ekir.2024.02.1439","article-title":"Nedosiran safety and efficacy in PH1: interim analysis of PHYOX3","volume":"9","author":"Groothoff","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2024.10.006_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.kint.2021.03.031","article-title":"A\u00a0report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3","volume":"100","author":"Martin-Higueras","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.10.006_bib10","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.kint.2019.08.018","article-title":"Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up","volume":"96","author":"Garrelfs","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.10.006_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0004563215606158","article-title":"Simultaneous analysis of urinary metabolites for preliminary identification of primary hyperoxaluria","volume":"53","author":"Clifford-Mobley","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.ekir.2024.10.006_bib12","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00467-017-3731-3","article-title":"Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type III","volume":"32","author":"Ventzke","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2024.10.006_bib13","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1046\/j.1523-1755.1998.00891.x","article-title":"Simultaneous determination of oxalate, citrate and sulfate in children\u2019s plasma with ion chromatography","volume":"53","author":"Hoppe","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.10.006_bib14","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/ki.2011.336","article-title":"Nephrocalcinosis and urolithiasis in children","volume":"80","author":"Habbig","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2024.10.006_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.10.006_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ekir.2023.10.004","article-title":"Multicenter long-term real world data on treatment with lumasiran in patients with primary hyperoxaluria Type 1","volume":"9","author":"Martin-Higueras","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2024.10.006_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780198805984.001.0001","author":"Raffle","year":"2019","journal-title":"Screening"},{"key":"10.1016\/j.ekir.2024.10.006_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/ijns10020038","article-title":"Current status of newborn bloodspot screening worldwide 2024: a comprehensive review of recent activities (2020\u20132023)","volume":"10","author":"Therrell","year":"2024","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.ekir.2024.10.006_bib18","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/ndt\/10.12.2224","article-title":"Changing pattern of primary hyperoxaluria in Switzerland","volume":"10","author":"Kopp","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.10.006_bib19","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1093\/ndt\/gfs320","article-title":"Primary hyperoxaluria type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort","volume":"27","author":"van der Hoeven","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2024.10.006_bib20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000086358","article-title":"Primary hyperoxaluria- the German experience","volume":"25","author":"Hoppe","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2024.10.006_bib21","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1681\/ASN.2014070698","article-title":"Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria","volume":"26","author":"Hopp","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.10.006_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41581-022-00661-1","article-title":"Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope","volume":"19","author":"Groothoff","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2024.10.006_bib23","first-page":"316","article-title":"Clinical and economic impact of primary hyperoxaluria: a retrospective claims analysis","volume":"28","author":"Mucha","year":"2022","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.ekir.2024.10.006_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41573-019-0049-9","article-title":"Therapies for rare diseases: therapeutic modalities, progress and challenges ahead","volume":"19","author":"Tambuyzer","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ekir.2024.10.006_bib27","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.ajhg.2022.08.003","article-title":"A\u00a0genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseases","volume":"109","author":"Kingsmore","year":"2022","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ekir.2024.10.006_bib28","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2023.05.007","article-title":"Actionability of unanticipated monogenic disease risks in newborn genomic screening: findings from the BabySeq Project","volume":"110","author":"Green","year":"2023","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ekir.2024.10.006_bib32","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1038\/s41467-022-31446-6","article-title":"An automated 13.5 hour system for scalable diagnosis and acute management guidance for genetic diseases","volume":"13","author":"Owen","year":"2022","journal-title":"Nat Commun"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924019648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924019648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T09:11:41Z","timestamp":1734945101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024924019648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2468024924019648"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2024.10.006","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective Newborn Screening for Type 1 and 3 Primary Hyperoxaluria","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2024.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}